Cargando…
Plasma biomarkers associated with survival and thrombosis in hospitalized COVID-19 patients
Severe coronavirus disease-19 (COVID-19) has been associated with fibrin-mediated hypercoagulability and thromboembolic complications. To evaluate potential biomarkers of coagulopathy and disease severity in COVID-19, we measured plasma levels of eight biomarkers potentially associated with coagulat...
Autores principales: | Cabrera-Garcia, David, Miltiades, Andrea, Yim, Peter, Parsons, Samantha, Elisman, Katerina, Mansouri, Mohammad Taghi, Wagener, Gebhard, Harrison, Neil L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Nature Singapore
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9395834/ https://www.ncbi.nlm.nih.gov/pubmed/35994163 http://dx.doi.org/10.1007/s12185-022-03437-2 |
Ejemplares similares
-
A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19
por: Wagener, Gebhard, et al.
Publicado: (2022) -
Mortality and renal outcomes of patients with severe COVID-19 treated in a provisional intensive care unit
por: Hittesdorf, Erin, et al.
Publicado: (2021) -
Predicting Poor Outcome of COVID-19 Patients on the Day of Admission with the COVID-19 Score
por: Tseng, Luke, et al.
Publicado: (2021) -
Anesthetic Resource Limitations and Adaptations in Times of Shortage: Experiences from New York Presbyterian Hospital During COVID-19
por: Wang, David S., et al.
Publicado: (2021) -
Rivaroxaban for the treatment of cerebral venous thrombosis
por: Esmaeili, Sara, et al.
Publicado: (2021)